Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.54 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.46 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12629111 | 0.86 | ALDH1A1 (0.51) | ALDH1A1DDB1CRBNMAPK1L3MBTL1 | |
| SCHEMBL19151347 | 0.86 | ALDH1A1 (0.51) | ALDH1A1DDB1CRBNMAPK1L3MBTL1 | |
| SCHEMBL19929365 | 0.85 | ALDH1A1 (0.60) | ALDH1A1DDB1CRBNMAPK1L3MBTL1 | |
| SCHEMBL19929364 | 0.85 | ALDH1A1 (0.51) | ALDH1A1DDB1CRBNMAPK1L3MBTL1 | |
| SCHEMBL29028887 | 0.81 | ALDH1A1 (0.46) | ALDH1A1DDB1CRBNMAPK1L3MBTL1 | |
| SCHEMBL6709368 | 0.78 | ALDH1A1 (0.54) | ALDH1A1DDB1CRBNMAPK1L3MBTL1 | |
| SCHEMBL11261518 | 0.78 | SMN1; SMN2 (0.47) | ALDH1A1MAPK1KMT2ANPC1RAB9A | |
| SCHEMBL14967622 | 0.78 | L3MBTL1 (0.44) | ALDH1A1MAPK1L3MBTL1TDP1RAB9A | |
| SCHEMBL11368685 | 0.78 | ALDH1A1 (0.53) | ALDH1A1DDB1CRBNMAPK1L3MBTL1 | |
| SCHEMBL1256462 | 0.76 | ALDH1A1 (0.51) | ALDH1A1DDB1CRBNMAPK1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180065948-A1 | Method for Synthesizing Cyclic Carbonates | HENKEL AG & CO. KGAA (DE) | 2018-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180065948-A1 | Method for Synthesizing Cyclic Carbonates | CA2, CA12, CA13 | ALDH1A1 4799/4885DDB1 3987/4885CRBN 367/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.